Position in IDYA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$8,540,515
-$1,054,734 QoQ
Shares Held
256,318
-7.7% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. IDYA ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in IDYA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,540,515 | 256,318 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $9,595,249 | 277,560 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,136,660 | 299,032 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,294,438 | 109,155 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,595,461 | 97,403 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,499,864 | 97,271 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,440,859 | 108,613 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,670,855 | 104,553 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,683,550 | 83,946 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||